Improvement of glycemic control after treatment with mosapride for diabetic gastropathy [2]

Diabetes Care

Volumn 23, Issue 8, 2000, Pages 1198-1199

  Koshiyama, Hiroyuki ^a   Shimono, Dai ^a   Wada, Yoshiahru ^a   Nakamura, Yoshio ^a  

^a HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; MOSAPRIDE CITRATE; PROKINETIC AGENT; SEROTONIN 4 AGONIST;

ADULT; AGED; CLINICAL ARTICLE; DIABETES CONTROL; DRUG EFFECT; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 0033865142     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.8.1198     Document Type: Letter

References (7)

1. The pathophysiology of diabetic gastroenteropathy: More vague than vagal?
2. Diabetic gastropathy: Gastric neuromuscular dysfunction in diabetes mellitus: A review of symptoms, pathophysiology, and treatment
3. Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis
4. A double-blinded multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis
5. Improvement of gastric emptying in diabetic gastroparesis by erythromycin: Preliminary studies
6. Effect of AS-4370 on gastric motility in patients with diabetic autonomic neuropathy
7. Mosapride (AS-4370) a new gastrokinetic agent, is a partial 5-HT4 receptor agonist in the gut